Trial intelligence / Profile preview

Gammanol cream versus mometasone cream for hand eczema

IRCT20201101049215N1Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
Nov 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of mometasone in hand dermatitis (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Hand Eczema Severity Index change and Dermatology Life Quality Index change. Started Nov 2019; status: completed.

02

Drugs

mometasone
03

Conditions

hand dermatitis

Beyond the preview

Go deeper on IRCT20201101049215N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20201101049215N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call